Some patients report changes in appetite and satiety, including increased cravings, larger portion sizes, and reduced fullness between meals
Indeed, several independent mechanisms are also reported to act in concert in order to result in enhanced insulin secretion, as discussed below (Figure 1)
Who Should Consider IGF-1 LR3 IGF-1 LR3 is appropriate for: Experienced users already running a solid foundation (training, protein, sleep) People in an active recomposition phase wanting to accelerate lean muscle accrual Those already running or familiar with GH secretagogues who want to add direct IGF-1 receptor stimulation It's not appropriate for: Beginners who haven't first established a baseline with training and nutrition Anyone with active cancer history or elevated PSA (IGF-1 is mitogenic it drives cell growth, not selectively) People not monitoring blood glucose (hypoglycemia risk is real) Dosing Starting Dose 2030 mcg post-workout
[DOI] [PMC free article] [PubMed] [Google Scholar] Sahebkar A., Serban C., Ursoniu S
However, some individuals report experiencing warmth, flushing, or temperature fluctuations during treatment
